172 results on '"Giallongo, C"'
Search Results
2. High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling
3. P01 LACTATE TRAFFICKING INHIBITION RESTORES SENSITIVITY TO PROTEASOME INHIBITHORS AND ORCHESTRATES IMMUNOMICROENVIRONMENT IN MULTIPLE MYELOMA
4. MACROH2A1.1 SITS AT THE INTERPLAY BETWEEN EPIGENETICS AND INFLAMMATION OF MESENCHYMAL STROMAL CELLS IN MYELODYSPLASTIC SYNDROMES
5. P02 ARGININE DEPRIVATION INDUCES ACQUISITION OF A SENESCENT PHENOTYPE AND FAVORS GENOMIC INSTABILITY IN MULTIPLE MYELOMA PLASMACELLS
6. P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA
7. O02 - MACROH2A1.1 SITS AT THE INTERPLAY BETWEEN EPIGENETICS AND INFLAMMATION OF MESENCHYMAL STROMAL CELLS IN MYELODYSPLASTIC SYNDROMES
8. P1288: ALTERED AMINO ACID HOMEOSTASIS CAN ELICIT AN ADAPTIVE RESPONSE VIA UPREGULATION OF UFMYLATION IN HODGKIN LYMPHOMA
9. P731: INTERPLAY BETWEEN INFLAMMATION AND EPIGENETICS IN TUMOR REPROGRAMMING OF MESENCHYMAL STROMAL CELLS (MSCS) IN MYELODYSPLASTIC SYNDROMES (MDS)
10. P870: DEFINING A NOVEL FUNCTION FOR THE POST-TRANSLATIONAL MODIFICATION UFMYLATION IN THE ADAPTIVE RESPONSE TO ARGININE DEPRIVATION IN MULTIPLE MYELOMA
11. P988: LACTATE RESHAPES TUMOR MICROENVIRONMENT AND METABOLIC PROFILE IN MYELOFIBROSIS
12. Hedgehog signaling pathways in multiple myeloma
13. P01: ARGININE STARVATION IN MULTIPLE MYELOMA MICROENVIRONMENT CONVEYS BORTEZOMIB REFRACTORINESS VIA TLR4 PATHWAY.
14. Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project
15. Mitochondrial functions, energy metabolism and protein glycosylation are interconnected processes mediating resistance to bortezomib in multiple myeloma cells
16. BRIT1/MCPH1 Expression in Chronic Myeloid Leukemia and Its Regulation of the G2/M Checkpoint
17. Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5)
18. Biological properties of itraconazole-SLNs
19. PS1362 TRYPTOPHAN DEPRIVATION DUE TO INCREASED IDO-1 TRIGGERS A METABOLIC ADAPTIVE RESPONSE AND DOWN-REGULATES CD38 IN MULTIPLE MYELOMA
20. PF658 THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IS A CHEAP SURROGATE OF EXPANSION OF MYELOID-DERIVED SUPPRESSOR CELLS IN MYELOFIBROSIS BEFORE AND AFTER TREATMENT WITH RUXOLITINIB: A SINGLE-CENTER EXPERIENCE
21. PF585 GENE-EXPRESSION PROFILE OF HIGH-DENSITY NEUTROPHILS REVEALS PROGRESSIVE DIFFERENCES IN MGUS AND MULTIPLE MYELOMA, ASSOCIATED WITH REDUCED PHAGOCYTOSIS AND INCREASED INFECTION SUSCEPTIBILITY
22. PS1363 TARGETING MITOCHONDRIAL FITNESS OF MYELOMA CELLS WITH TAK-242 OVERCOMES BORTEZOMIB RESISTANCE
23. MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA
24. IN MULTIPLE MYELOMA THERE ARE TWO SUBSETS OF IMMUNOSUPPRESSIVE POLYMORPHONUCLEAR NEUTROPHILS WITH INCREASED LEVELS OF ARGINASE
25. Heme oxygenase 1 (HO-1) protects myeloma cells against bortezomib through nuclear translocation and regulation of ER stress and autophagy proteins
26. GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS (G-MDSC) ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS (MSC)
27. UP-REGULATION OF PROK-2/BV8 IN GRANULOCYTES IS PRESENT BOTH IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND MULTIPLE MYELOMA
28. IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA
29. MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION
30. OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE
31. BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION
32. Role of nuclear heme oxygenase 1 in bortezomib induced cell death and genomic instability of multiple myeloma cells 100:157. 45th Congress of the Italian-Society-of-Hematology, Florence, ITALY, OCT 04-07, 2015
33. Biological properties of Cakile maritima Scop. (Brassicaceae) extracts.
34. Bortezomib induced expression of heme oxygenase 1 via endoplasmic reticulum stress 19th Congress of the European-Hematology-Association. Milan, ITALY. Jun 12-15, 2014
35. Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors
36. Heme oxygenase 1-induced resistance to imatinib in chronic myelogenous leukemia cells
37. Role of Nuclear Heme Oxygenase 1 (HO-1) in Bortezomib Induced Cell Death and Genomic Instability of Multiple Myeloma (MM) Cells
38. Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression
39. Granulocyte-like Myeloid Derived Suppressor Cells (G-MDSCs) are increased in Multiple Myeloma due to immunological dysregulation of mesenchymal stem cells (MSCs)
40. MYELOID-DERIVED SUPPRESSOR CELLS IN PATIENTS WITH MULTIPLE MYELOMA AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
41. LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS
42. THE ROLE OF SPARC IN CHRONIC MYELOID LEUKEMIA
43. DOWNREGULATION OF ANTIAPOPTOTIC GENES INDUCED BY IMATINIB/MELPHALAN COMBINATION INCREASES KILLING OF CHRONIC MYELOID LEUKEMIA CELLS
44. Role of Heme Oxygenase 1 during in vitro osteoblastic differentiation from Human Mesenchimal stem cells cultured in high glucose medium
45. BRIT1 REGULATES G2/M CHECKPOINT IN CHRONIC MYELOID LEUKEMIA
46. Ruolo dell'eme ossigenasi 1 nella resistenza ad imatinib mesilate in cellule di leucemia mieloide cronica
47. Dasatinib e nilotibin favoriscono la differnziazione in osteoblasti delle cellule staminali mesenchinali del midollo osseo
48. IMATINIB AND DASATINIB INCREASE CYTOTOXICITY OF MELPHALAN AND DECREASES DELAY OF G2-M TRANSITION IN HUMAN K562 CHRONIC MYELOID LEUKEMIA CELLS
49. ROLE OF HEME OXYGENASE 1 IN CML CELLS RESISTANT TO IMATINIB
50. BRIT1 REGULATES G2/M CHECKPOINT IN CHRONIC MYELOID LEUKEMIA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.